Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia.
暂无分享，去创建一个
I. Marugán | V. Guillem | J. Cervera | B. Bellosillo | M. Maffioli | F. Cervantes | F. Martínez-Ruiz | J. Hernández-Boluda | M. Collado | A. Álvarez-Larrán | P. Amat | J. Hernández‐Boluda